Table 2.
DFS |
OS |
|||||
---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% CI | p-value | |
age, years | ||||||
<65 | — | — | ||||
≥65 | 1.009 | 0.659–1.841 | 0.714 | 0.934 | 0.530–1.644 | 0.822 |
AJCC stage | ||||||
I | — | — | ||||
II | 1.108 | 0.305–4.027 | 0.877 | 0.667 | 0.201–2.215 | 0.518 |
III | 6.823 | 2.097–22.199 | 0.001* | 3.401 | 1.184–9.771 | 0.026* |
IV | 49.185 | 12.615–191.764 | <0.001* | 40.074 | 11.257–142.668 | <0.001* |
differentiation | ||||||
high | — | — | ||||
moderate | 1.315 | 0.750–2.306 | 0.341 | 1.458 | 0.764–2.780 | 0.273 |
low | 3.577 | 1.885–6.786 | <0.001* | 4.358 | 2.140–8.872 | <0.001* |
vascular invasion | ||||||
yes | 4.901 | 2.469–9.721 | <0.001* | 4.638 | 2.152–9.997 | <0.001* |
no | — | — | ||||
miR-125a-5p | ||||||
high | — | — | ||||
low | 6.118 | 3.004–12.462 | <0.001* | 6.348 | 2.875–14.014 | <0.001* |